Abstract
Deciding whether to grant an expanded access request for a child whose sibling is enrolled in a gene therapy trial involves a number of complex factors: considering the best interests of the child, the psychosocial and economic impact on the family, and the concerns and obligations of researchers. Despite the challenges in coming to a substantively fair outcome in cases of discordant eligibility, creating a procedurally fair decision-making process to adjudicate requests is essential.
Original language | English |
---|---|
Pages (from-to) | 359-363 |
Number of pages | 5 |
Journal | Clinical Ethics |
Volume | 16 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2021 |
Keywords
- Bioethics and medical ethics
- biomedical research
- expanded access
- gene therapy
- justice
- pediatrics